Euglycemic Clamp Study Comparing Two New Insulin Glargine Formulations in Subjects With Type 1 Diabetes Mellitus
NCT01838083
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Type1 Diabetes
Interventions
DRUG:
Insulin glargine new formulation HOE901
Sponsor
Sanofi